<DOC>
	<DOCNO>NCT00441129</DOCNO>
	<brief_summary>. PRIMARY ENDPOINT The primary endpoint change baseline ( Visit 3 ) 6 month ( Visit 6 ) centrally measure HbA1c SECONDARY ENDPOINTS 1 . Change baseline mean blood glucose value calculate CGMS recording . 2 . Change baseline occurrence hyperglycemia 190 mg/dl . 3 . Change baseline occurrence hypoglycemia 70 mg/dl 4 . Change baseline insulin dos . 5 . Total daily use insulin . 6 . % daily use insulin basal rate . 7 . % daily use insulin bolus . 8 . Patient Satisfaction questionnaire . 9 . Health economic questionnaire . 10 . Quality life questionnaire</brief_summary>
	<brief_title>Obtain Good Blood Glucose Control With Paradigm Real Time System</brief_title>
	<detailed_description>The long-term clinical benefit tight glycemic control people diabetes well know . HbA1c generally assess average/long term quality glycemic control , clearly demonstrate target HbA1c 7.0 % le benefit diabetic patient</detailed_description>
	<criteria>Patient sign informed consent form prior study entry . Patients diagnose Type 1 DM least 12 month prior inclusion . Patients receive diabetes care investigator center least 3 month prior inclusion . Patients treat multiple daily injection use rapid Insulin Analog meal prior study entry . Have HbA1c value ≥ 8 % . Pediatric patient must age 2 18 year old adult patient age 19 65 year old . Patients must perform least 3 selfmonitoring blood glucose fingersticks daily . Patients PRT group must willing wear sensor transmitter connect pump Paradigm® RealTime 24 week change sensor , insulin infusion set reservoirs every 3 day ( ~60 time study period ) . Patients CSII group must willing wear insulin pump , change insulin infusion set , reservoir every 3 day ( ~60 time study period ) . Patient require use Paradigm® RealTime system least 70 % time study period . Patients group require wear begin end study CGMS 3 day . perform 6 selfmonitoring blood glucose fingersticks daily 3 day . Patients must willing undergo study procedure , receive technical training understand use Paradigm® RealTime System Insulin Pump depend randomization . Patients must agree receive training adapt insulin dose meal , calculate apply corrective treatment . Hearing vision impairment alarm recognize . Alcohol drug abuse nicotine . Allergy sensor component sensor . Allergy insulin infusion set component insulin infusion set . Patient pregnant childbearing potential study . Patient reliable support person patient unwilling comply provision protocol . Patients suffer cancer , heart failure , kidney disease chronic debilitating condition . Patients participate device drug study exclude . Patients may participate study .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>Improvement blood glucose control</keyword>
</DOC>